|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.040 USD | +0.49% |
|
-28.92% | -29.17% |
| 07-30 | Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc. for approximately $320 million. | CI |
| 07-30 | Processa Pharmaceuticals, Inc. - M&A Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 3.18 | 3.18 | 4.295 |
| Spread/Res. | -35.85% | -35.85% | -52.50% |
| Spread/Supp. | +10.27% | +10.27% | +9.68% |
| Support | 1.85 | 1.85 | 1.86 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PCSA Stock
- Charts Processa Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
